PrEP 30

Phase:Demo Project
Principal Investigator(s):
Objective:PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.
Prevention Option(s):PrEP
Study Design:
Official Code: NCT02437981
Trial Sponsors: Thai Red Cross
Start Date
End Date
December 12, 2014
January 1, 2021
Age range: 18 Years ↔ any
Population:Cisgender Men, Cisgender Women, Gay and Bisexual Men Who Have Sex with Men